Connection
Jeffrey Swigris to Fibrosis
This is a "connection" page, showing publications Jeffrey Swigris has written about Fibrosis.
|
|
Connection Strength |
|
 |
|
 |
|
0.218 |
|
|
|
-
Aronson K, Jacobs SS, Repola D, Swigris JJ. Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how? BMJ Open Respir Res. 2023 07; 10(1).
Score: 0.173
-
Wijsenbeek M, Swigris JJ, Inoue Y, Kreuter M, Maher TM, Suda T, Baldwin M, Mueller H, Rohr KB, Flaherty KR. Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis. Eur Respir J. 2024 Feb; 63(2).
Score: 0.045